Neurological manifestation of immune system dysregulation resulting from CTLA-4 receptor mutation: a case report
| Authors | |
|---|---|
| Year of publication | 2020 |
| Type | Article in Periodical |
| Magazine / Source | MULTIPLE SCLEROSIS AND RELATED DISORDERS |
| MU Faculty or unit | |
| Citation | |
| Web | https://doi.org/10.1016/j.msard.2020.102313 |
| Doi | http://dx.doi.org/10.1016/j.msard.2020.102313 |
| Keywords | CTLA-4 antigen; T-lymphocytes; Autoimmunity; Genetic diseases; Demyelinating diseases |
| Description | This contribution reports the case of a young female patient with a cytotoxic T-lymphocyte antigen 4 (CTLA-4) heterozygous missense mutation giving rise to a broad range of autoimmune diseases, including central nervous system inflammation presenting as disseminated intramedullary and infiltrating brain lesions on MRI. Multiple sclerosis was one of the diagnoses considered. CTLA-4 is a negative immune regulator essential for the function of regulatory T-cells, themselves responsible for maintaining self-tolerance and immune homeostasis. Heterozygous germline mutations in CTLA-4 may lead to an autosomal dominant immune dysregulation syndrome with highly variable phenotype, including various immunodeficiency and autoimmune diseases, along with neurological manifestations. |
| Related projects: |